Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Fox Chase Cancer Center
With
United States Department of Defense
Creatv Microtech, Inc.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Referral for a pulmonary nodule that has not yet been biopsied and that meets the definition of an "indeterminate" nodules (i.e. 0.8-3.0 cm).
No prior diagnosis of lung cancer or other invasive malignancy within the past 5 years.
No history of rheumatologic disease.
Age \> 18 years.
Ability to understand and willingness to sign a written informed consent and HIPAA consent document
You may not be if
Patients with active, known or suspected autoimmune disease.
Prior diagnosis of lung cancer or other invasive malignancy within the past 5 years.
Uncontrolled intercurrent illness that would increase the risk of toxicity or limit compliance with study requirements. This includes but is not limited to, uncontrolled infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements.
Known HIV-positive patients on combination antiretroviral therapy are ineligible because of the abnormal immune response that results from HIV disease (testing is not required).
Patients should be excluded if they are known to be positive for hepatitis B virus surface antigen (HBV sAg) or hepatitis C virus ribonucleic acid (HCV antibody) indicating acute or chronic infection (testing is not required).
Subjects with any history of interstitial lung disease or a history of \> or = to grade 2 radiation pneumonitis.
Clareo Health | Utility of CAML as Diagnostic for Early Stage Lung Cancer
